| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 144 |
| 1 | OXALIPLATIN | 115 |
| 2 | PREDNISONE | 93 |
| 3 | TACROLIMUS | 85 |
| 4 | CYCLOPHOSPHAMIDE | 83 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 83 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 83 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 81 |
| 8 | TACROLIMUS OINTMENT 0.1% | 81 |
| 9 | MYCOPHENOLATE MOFETIL | 78 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSAMPRENAVIR CALCIUM | 2 | 0.0153 |
| 1 | AESCULUS HIPPOCASTANUM WHOLE | 1 | 0.0133 |
| 2 | AGRIMONIA EUPATORIA | 1 | 0.0132 |
| 3 | CENTAURIUM ERYTHRAEA | 1 | 0.0130 |
| 4 | TERLIPRESSIN | 3 | 0.0091 |
| 5 | ADO-TRASTUZUMAB EMTANSINE | 53 | 0.0063 |
| 6 | TRASTUZUMAB-QYYP | 2 | 0.0051 |
| 7 | NELFINAVIR MESYLATE | 10 | 0.0048 |
| 8 | NEVIRAPINE | 41 | 0.0046 |
| 9 | ZIDOVUDINE | 39 | 0.0038 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 3 | 0.0091 |
| 1 | CD22-directed Immunoconjugate [EPC] | 7 | 0.0023 |
| 2 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 50 | 0.0021 |
| 4 | Purine Antimetabolite [EPC] | 144 | 0.0015 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 55 | 0.0011 |
| 6 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 7 | Protease Inhibitor [EPC] | 32 | 0.0007 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 62 | 0.0006 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 32 | 0.0005 |